Beyond the joints, the extra-articular manifestations in rheumatoid arthritis

A Conforti, I Di Cola, V Pavlych, P Ruscitti… - Autoimmunity …, 2021 - Elsevier
Rheumatoid arthritis (RA) is an inflammatory disease typically affecting the joints, but the
systemic inflammatory process may involve other tissues and organs. Many extra-articular …

[HTML][HTML] Helicobacter pylori infection and autoimmune diseases; Is there an association with systemic lupus erythematosus, rheumatoid arthritis, autoimmune atrophy …

M Youssefi, M Tafaghodi, H Farsiani, K Ghazvini… - Journal of Microbiology …, 2021 - Elsevier
Autoimmune diseases are considered as one of the most important disorders of the immune
system, in which the prolonged and chronic processes eliminate self-tolerance to the auto …

HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19

M Tian, W Liu, X Li, P Zhao, MA Shereen… - … and Targeted Therapy, 2021 - nature.com
Cytokine storm induced by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-
2) is a major pathological feature of Coronavirus Disease 2019 (COVID-19) and a crucial …

Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection

M Biggioggero, C Crotti, A Becciolini… - Drug design …, 2018 - Taylor & Francis
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by articular and
systemic manifestations, such as anemia, fatigue, osteoporosis, and increased risk for …

Clinical and immunological parameters of Sjögren's syndrome

K Psianou, I Panagoulias, AD Papanastasiou… - Autoimmunity …, 2018 - Elsevier
Sjögren's syndrome (SS) is a chronic autoimmune disease that primarily affects the exocrine
glands, resulting in their functional impairment. In SS, lymphocytic infiltration of salivary and …

Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases

P Di Benedetto, P Ruscitti, Z Vadasz, E Toubi… - Autoimmunity …, 2019 - Elsevier
Macrophages are pivotal cells involved in chronic inflammatory and autoimmune diseases.
In fact, during these diseases, activated macrophages may play a critical role, promoting the …

Failure of anti-TNF treatment in patients with rheumatoid arthritis: the pros and cons of the early use of alternative biological agents

A Rubbert-Roth, MZ Szabó, M Kedves, G Nagy… - Autoimmunity …, 2019 - Elsevier
The five TNF inhibitors currently approved for the treatment of RA are characterised by
differences in their molecular structures, half-lives, administration routes, dosing intervals …

Guidelines for biomarkers in autoimmune rheumatic diseases-evidence based analysis

R Giacomelli, A Afeltra, A Alunno, E Bartoloni-Bocci… - Autoimmunity …, 2019 - Elsevier
Autoimmune rheumatic diseases are characterised by an abnormal immune system
response, complement activation, cytokines dysregulation and inflammation. In last years …

M281, an anti‐FcRn antibody: pharmacodynamics, pharmacokinetics, and safety across the full range of IgG reduction in a first‐in‐human study

LE Ling, JL Hillson, RG Tiessen, T Bosje… - Clinical …, 2019 - Wiley Online Library
M281 is a fully human, anti‐neonatal Fc receptor (FcRn) antibody that inhibits FcRn‐
mediated immunoglobulin G (IgG) recycling to decrease pathogenic IgG while preserving …

The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a survey of 1000 consecutive cases

J Alijotas-Reig, E Esteve-Valverde… - Autoimmunity …, 2019 - Elsevier
Aim To analyse the clinical features, laboratory data and foetal-maternal outcomes, and
follow them up on a cohort of 1000 women with obstetric antiphospholipid syndrome …